Skip to main content
. 2016 Feb 24;24(4):227–236. doi: 10.1007/s12471-016-0810-1

Fig. 3.

Fig. 3

Comorbidities drive myocardial dysfunction and remodelling in HFPEF. IL-6 interleukin-6; sST2 soluble ST2; TNF-α tumour necrosis factor alfa; VCAM vascular cell adhesion molecule. Modified with permission from [28]